Oxycodone 30mg (A215)

Oxycodone 30mg is a single-ingredient, high-concentration formulation of oxycodone hydrochloride designed for patients whose pain responds inadequately to lower-strength opioid products. This immediate-release tablet is indicated exclusively for the short-term management of severe acute pain that requires potent opioid intervention and for which non-opioid alternatives are unsuitable.

As a semi-synthetic derivative of thebaine, oxycodone interacts with mu, kappa, and delta opioid receptors distributed throughout the central nervous system and peripheral tissues. This broad receptor engagement produces pronounced analgesia by modulating neurotransmitter release and altering nociceptive signaling pathways. The 30mg strength is reserved for individuals who have established tolerance to opioid therapy, as this dose represents the upper range of commercially available single-tablet oxycodone products.

The immediate-release nature of this tablet ensures that patients experience rapid uptake and subsequent pain control, a critical feature for acute conditions where time-to-relief directly impacts patient comfort and functional recovery. For those who have exhausted other pharmacological options, Oxycodone 30mg provides the intensive support needed to navigate severe pain episodes while participating in essential rehabilitative activities.

Key Product Features

Important Safety Information

Oxycodone is a potent opioid and should be used exclusively under healthcare supervision. Oxy 30mg is indicated only for patients with demonstrated opioid tolerance and severe pain unresponsive to lower-dose alternatives.

Critical Warnings:

• Fatal Overdose Risk: The 30mg tablet contains a substantial quantity of oxycodone. Crushing, chewing, or dissolving the tablet bypasses the intended release mechanism, leading to rapid systemic absorption and potentially fatal respiratory depression.

• Hypotension and Circulatory Compromise: High-dose oxycodone can cause severe vasodilation and hypotension, particularly in patients with reduced blood volume or concurrent use of certain antihypertensive agents.

• Serotonin Syndrome: Although less common than with other opioids, concomitant use with serotonergic drugs may precipitate serotonin syndrome, a potentially life-threatening condition characterized by autonomic instability and neuromuscular excitation.

• Opioid-Induced Hyperalgesia: Paradoxically, prolonged use of high-dose opioids can increase pain sensitivity, complicating pain management and necessitating careful dose reassessment.

Common Side Effects:
Patients frequently encounter constipation, nausea, somnolence, lightheadedness, and pruritus (itching), particularly during the initial dosing period.

Dosing Considerations

The 30mg strength is not appropriate for opioid-naive patients and should only be prescribed following careful risk-benefit analysis.

General Dosing Guidelines:

Administration and Storage Instructions

This medication must be swallowed intact. Altering the tablet in any way represents a significant safety hazard.

Administration Protocol:

1. Place the tablet on the tongue and swallow with water without chewing or crushing.

2. Consistent timing relative to meals is recommended to maintain predictable absorption.

3. Do not pre-soak or dissolve the tablet in any liquid.

4. Adhere strictly to prescribed dosing intervals without self-adjustment.

5. Consult your provider before any dose modification.

Storage Requirements:
Maintain at controlled room temperature (20°C–25°C) in a dry environment. Preserve the original packaging until administration.

Disposal Protocol:
Return unused tablets to authorized collection points. Do not discard in household waste or plumbing systems.

Frequently Asked Questions

Q: Is oxycodone 30 mg a strong painkiller?
A: Yes, 30mg of oxycodone is among the highest single-tablet doses available for outpatient use. It is considered a strong opioid, approximately 1.5 to 2 times more potent than morphine on a milligram basis. This strength is appropriate only for patients who have developed tolerance through prior opioid exposure; using this dose without established tolerance poses a significant risk of life-threatening respiratory depression.

Q: How long does 30 mg of oxycodone last?
A: The immediate-release 30mg tablet provides effective pain relief for approximately 3 to 6 hours per dose. Peak plasma concentrations occur roughly one hour after administration, after which the analgesic effect gradually declines. Patients typically require redosing every 4 to 6 hours to maintain consistent pain control, depending on individual metabolic factors and the severity of their underlying condition.